CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Aion Therapeutic Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Aion Therapeutic Inc
700 West Georgia Street, Suite 2200
Phone: (604) 558-4300p:604 558-4300 ONTARIO, ON  V7Y 1K8  Canada Ticker: AIONAION
Business Summary
Aion Therapeutic Inc. is a Canada-based company that operates within the health and wellness sector. The Company offers various formulations which help with obesity, viral diseases, inflammation, mental health, and cancer. It has developed novel compositions and methods useful for promoting weight loss and in the treatment of obesity. These nutraceutical and pharmaceutical compositions comprise mushrooms or their extracts, cannabis extracts, terpenes, flavonoids, and other botanicals with known health benefits. Its inflammation formulations are applicable to both chronic and acute inflammation. Its Mental Health formulations use AI to create optimized compositions and methods useful in the treatment of psychotic disorders including depression, anxiety, PTSD, addictions and substance abuse, and related psychological conditions. Its cancer formulations are able to target multiple types of cancer based on AI-optimized compositions that are both cancer-type specific and patient-specific.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20254/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
4941 Water supply

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director GrahamSimmonds 1/16/2020 1/16/2020
Chief Financial Officer Rakesh K.Malhotra 63 1/3/2019 1/3/2019
Director Stephen D.Barnhill
3 additional Officers and Directors records available in full report.

Business Names
Business Name
1196691 B.C. Ltd.
Agr-O Phosphate Inc.
AION
4 additional Business Names available in full report.

General Information
Outstanding Shares: 497,149,269 (As of 1/31/2025)
Stock Exchange: CNQ
Fax Number: (778) 480-6455


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 12, 2025